60 degrees pharmaceuticals announces closing of $2.4 million public offering

Washington, jan. 31, 2024 (globe newswire) -- 60 degrees pharmaceuticals , inc. (nasdaq: sxtp; sxtpw) (“60 degrees pharmaceuticals” or the “company”), specialists in developing and marketing new medicines for the treatment and prevention of infectious diseases, announced today the closing of its public offering of 5,260,901 units (the “units”) at a price to the public of $0.385 per unit and 999,076 pre-funded units (the “pre-funded units”) at a price to the public of $0.375 per pre-funded unit. each unit consists of one share of common stock and one warrant exercisable for one share of common stock (the “warrant”).
SXTP Ratings Summary
SXTP Quant Ranking